$BNTC
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Healthcare
Sector
Biotechnology
Industry
Jerel A. Banks
CEO
16
Employees
$10.98
Current Price
$272.44M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 1 | 6 | $1,903,132.88 | 144,223 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Dec 29, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | 11,587 | $13.44 | $155,729.28 | View Details |
| Dec 23, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | 42,600 | $12.85 | $547,410.00 | View Details |
| Dec 26, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | 2,516 | $13.10 | $32,959.60 | View Details |
| Dec 26, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | 14,320 | $13.10 | $187,592.00 | View Details |
| Dec 23, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | 7,400 | $12.85 | $95,090.00 | View Details |
| Dec 29, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | 65,800 | $13.44 | $884,352.00 | View Details |
| Dec 22, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | 16,650 | $12.08 | $201,132.00 | View Details |
| Dec 22, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | 2,892 | $12.08 | $34,935.36 | View Details |
12 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
EPS
Estimated-$0.23
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.23
Actual-$0.26
Miss
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: